Comment
Author: Admin | 2025-04-28
The United States.Your questions, answered: What should Canadians know about donanemab (Kinsula) Alzheimer Society of Canada. In July 2023, American drug company Eli Lilly and Company released full results from a Phase 3 trial of donanemab, a drug that aims to target Alzheimer’s disease. This webpage is information that people in Canada may want to know about this.Drug approval process for the treatment of Alzheimer’s disease. Alzheimer Society of Canada. Get the full picture of how a drug gets approved for public use in Canada, including a list of the currently approved medications that can treat the symptoms of Alzheimer's disease.Treatment options. Alzheimer Society of Canada. This downloadable brochure gives an overview of all the treatment options for dementia that are available to you.Canada's provincial health plans. Special Benefits Insurance Services. This page is a helpful summary of the covered healthcare services in each province, with links to each plan on each respective province's government website.Last updated: May 30, 2024
Add Comment